We support your clinical staff with gentle, non-invasive procedures for early detection of bilirubin and for the treatment of neonatal hyperbilirubinemia in newborn babies. At-risk neonatal patients in your hospital can be identified early on, with minimal stress to the baby and parents alike, helping to reduce readmission rates.
The Dräger BiliLux is a compact and lightweight LED phototherapy light system for the treatment of neonatal unconjugated hyperbilirubinemia. It provides superior phototherapy performance, individualised therapy with electronic documentation capabilities and the flexibility for seamless integration into practically every workplace.
Learn more about Dräger BiliLux: https://www.draeger.com/en_uk/Products/BiliLux